Herantis Pharma's Manager's Transactions
Herantis Pharma's Manager's Transactions
Herantis Pharma Plc
Company release 22 Aug 2017 at 9:00 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Veromaa, Timo
Position: Member of the Board/Deputy member
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20170820223631_1
Transaction date: 2017-08-17
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: Optio-ohjelma 2014 (Optio- ja muut erityiset oikeudet P003)
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme
Transaction Details
(1): Volume: 12 Unit price: 0.00000 EUR
Aggregated transactions
(1): Volume: 12 Volume weighted average price: 0.00000 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site:
www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 246
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Herantis Pharma Oyj via GlobeNewswire